Lipa-KO

Fig.1 Body weight of Lipa-KO and WT C57BL/6 mice. (2~4 month: n=3~6; 6 month: n=1~3)

Fig.2 ALT and AST of Lipa-KO and WT C57BL/6 mice. (2~4 month: n=3~6; 6 month: n=1~3)

Fig.3 Blood lipid profile of Lipa-KO and WT C57BL/6 mice. (2~4 month: n=3~6; 6 month: n=1~3)

Fig.4 Cholesterol content of Lipa-KO and WT C57BL/6 mice in liver and spleen. (n=1~3).

Fig.5 Gross pathology and relative weight of liver of Lipa-KO and WT C57BL/6 mice. (n=1~3).

Fig. 6 Gross pathology and relative weight of spleen of Lipa-KO and WT C57BL/6 mice. (n=1~3).

Fig.7 Gross pathology and relative weight of small intestine of Lipa-KO and WT C57BL/6 mice. (n=1~3).

Fig.8 Relative weight of WAT of Lipa-KO and WT C57BL/6 mice. (n=1~3).

Fig.9 Representative oil‐red‐staining images of liver and spleen of of 3-month old mice Lipa-KO and WT C57BL/6 mice. 

Fig.10 Representative pictures of liver and spleen of 3-month old mice Lipa-KO and WT C57BL/6 mice. 

Macrophages (orange arrow), fibroblast proliferation (brown arrow), and granulocyte infiltration (red arrow).